P-522 A phase II trial of Alimta plus carboplatin (AC) in patients (pts) with advanced non-small-cell lung cancer (NSCLC)
Zinner R, Obasaju C, Fossella F, Pisters K, Papadimitrakopoulou V, Varghese B, Peeples B, Hatfield A, Hong W, Herbst R. P-522 A phase II trial of Alimta plus carboplatin (AC) in patients (pts) with advanced non-small-cell lung cancer (NSCLC). Lung Cancer 2003, 41: s223. DOI: 10.1016/s0169-5002(03)92489-5.Peer-Reviewed Original Research